Commiphora wightii (Arn.) Bhandari. Review of Its Botany, Medicinal Uses, Pharmacological Activities and Phytochemistry by Bhardwaj, Manisha & Alia, Aparna
Bhardwaj et al                                                                                                     Journal of Drug Delivery & Therapeutics. 2019; 9(4-s):613-621 
ISSN: 2250-1177                                                                                  [613]                                                                                 CODEN (USA): JDDTAO 
Available online on 15.08.2019 at http://jddtonline.info 
Journal of Drug Delivery and Therapeutics 
Open Access to Pharmaceutical and Medical Research 
© 2011-18, publisher and licensee JDDT, This is an Open Access article which permits unrestricted 
non-commercial use, provided the original work is properly cited 
Open  Access                                                                                                                                                                Review Article 
Commiphora wightii (Arn.) Bhandari. Review of Its Botany, Medicinal Uses, 
Pharmacological Activities and Phytochemistry 
Manisha Bhardwaj*, Aparna Alia 
Department of Botany, Rajeev Gandhi College, Trilanga, Bhopal-462039, (M.P), India. 
 
ABSTRACT 
The oldest remedies identified to mankind are herbal medicines. India is recognized worldwide for its Ayurvedic treatment. As only little 
studies are done on this plant, the purpose of current review is to make accessible up-to-date information on, botany, morphology, ecological 
biodiversity, medicinal uses, phytochemistry and pharmacological activities on diverse parts of Commiphora wightii (Arn.) Bhandari (C. wightii). 
This review was assembled using scientific literature from electronic search engine such as Springerlink, BioMed Central, PubMed, Scopus, 
ScienceDirect, Scielo, Medline and Science domain. Supplementary literatures were obtained from books, book chapters,  dissertations, websites 
and other scientific publications. C. wightii  (Syn. Commiphora mukul Hook. ex. Stocks) or Guggulu tree. C. wightii is a shrub or small tree 
belonging to Burseraceae family. C. wightii contains volatile oil, gum resin, gugulipids, guggulsterones, guggulsterols, mukolol and other 
steroids. Guggulu is very much used in Ayuvedic system of medicine as astringent, anti-septic, expectorant, aphrodisiac, carminative, anti-
spasmodic, emmenagogue. In Ayurveda, it is the best among herbs that are used for Medoroga and Vata disorders. It is widely used for obesity 
and it is also known as fat burning agent all over the world. It helps to lower cholesterol and triglycerides level. It is very effective in rheumatoid 
arthritis, gout and sciatica. It is also one of the most important Rasayana of Ayurveda. In addition it treats sluggish liver, stimulates libido, 
nervous diseases, bronchial congestion, cardiac and circulatory problems, weak digestion, wounds, abscess, foetid ear, fractures, gynaecological 
problems and various skin diseases. C. wightii is a very important and trustworthy herb in Ayurvedic medicine. This alternative system of 
medicine is gaining increasing fame universal. There is a required to isolate active constituents, their biological test, molecular mechanisms, 
experimental defense and legalization of therapeutic uses of C. wightii. The collected information will be obliging to locate up study protocol for 
current drugs and Ayurvedic formulation extension in remedial and luxury a variety of ailments. Clinical trials for the reported preclinical 
studies should be executed immediately to further validate the claims on humans. 
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Introduction 
Plants are significant to human being for his life. Plants are 
incessantly an ordinary source of medicine in the usage of 
traditional preparations. All plants phyla create official and 
illegal product of therapeutic significance. The antiquity of 
herbal medicine is as very old as human society. The 
treasure of India is stored in the huge natural flora, which 
has been advantage to mankind. India is almost herbarium 
of the planet1,2. Although the biologically active 
phytoconstituents of certain herbal drugs are unidentified, 
they are prescribed normally owing to their effectiveness, 
least side effects in clinical information and moderately very 
low costs3. Ornamental plants are grown for decorative 
purposes in gardens and scenery design projects, as house 
plants, for cut flowers and specimen exhibit. Ornamentals 
and flowers harvests are not only grown for the exhibit of 
aesthetic features, but also have nutritive and therapeutic 
properties. There has been rehabilitated interest in utilizing 
garden environments having therapeutic value, as 
therapeutic entities to improve the process of healing that 
occurs in healthcare environments. The use of plant 
complexes for pharmaceutical purpose has steadily 
increased in India, about 85% of individuals from urbanized 
countries use customary medicine, which involves 
compounds resulting from medicinal plants4. Flowering 
trees are now being browbeaten in the customary medicine 
and their curative potentials are well recognized. C. wightii 
with common names Indian bdellium tree, Gugal, Guggul, 
Guggulu, is a flowering plant belonging to family 
Burseraceae. The Guggul plant may be found from northern 
Africa to central Asia, but is most common in Northern India. 
It prefers arid and semi-arid climates and is tolerant of poor 
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soil. It is a shrub or small tree, reaching a maximum height of 
3m, with thin papery bark. C. wightii produces a resinous sap 
known as gum Guggul. The extract of this gum, called 
gugulipid or guglipid, has been used in Ayuvedic medicine 
abundantly. C. wightii contains essential oil, resin, gum, and 
bitter compounds. The major chemical constituents of C. 
wightii   are Z- guggulsterone, E-guggulsterone, 
guggullignans I & II, gugglu tetrols; mukulol; allylcembrol; c-
27 guggulusterols I, II, III; Z-guggulusterol; E-guggulusterol 
etc. These constituents are responsible for several 
pharmacological activities like anti-inflammatory, analgesic, 
cleaning of wound and healing due to its antibacterial action. 
C. wightii is a natural health product used primarily to 
reduce elevated blood cholesterol levels. It has been used for 
many years as a hypocholesterolaemic agent in India. C. 
wightii is one of the best rewarding herbs for Vata diseases. 
Various preparations of C. wightii used in sciatica, 
hemiplegia, gout, rheumatic diseases, facial paralysis etc. C. 
wightii is beneficial in cleansing and healing of wounds and 
to reduce oedema due to its anti-inflammatory and anti-
septic properties. In digestive ailments also like anorexia, 
flatulence, worm infestations, piles etc, it works well5,6. C. 
wightii is known as Marudeshya because it is a plant which 
grows in arid zone. It exudes a gum resin coming out of 
cavities (Kaushika, Ulukhala, Kumbholukhala) in form of 
particles (Kananiryasa) reddish black in colour (Mahishaksa, 
Kalaniryasa). It removes a number of ailments (Guggulu) 
particularly obesity (Palankasa) and is antiseptic (Rakshoha) 
as fumigation. It is also used as incense in god’s worship 
(Devadhupa)7. C. wightii is known as Ulukhala because it 
exudes a gum-resin which comes out from cavities. The resin 
is the best medicine, so it is known as Pura. It is also known 
as Durg because it is a plant which grows in arid zone8. The 
classification of C. wightii consist of domain: Eukaryota, 
kingdom: Plantae, sub-kingdom: Tracheobionta, division: 
Magnoliophyta, class: Spermatopsida, sub-class: 
Magnoliidae, order: Sapindales, genus: Commiphora, family: 
Burseraceae, species: wightii9. The vernacular names of the 
plant is Mukul, Guggul, Gugal, Gogil, (Hindi), Gukkal, 
Gukkulu, Maishakshi   (Tamil), Guggala, Gulag, Mukul 
(Marathi), Gugal, Gugali, Gugar, Guggul, Mukul, (Gujarat ), 
Gugul, Mahisaksh, Maisakshi  (Telgu) Aflatan, Moql, 
Moqlearzaqi, Mukulearabi (Arabic), Bhavabhishtha, 
Bhutahara, ect (Sanskrit)10. Therefore, in this study, the 
ethnopharmacological review of C. wightii was carried out 
aimed at providing a detailed précis of the botany, 
ethnomedicinal uses, pharmacological activities and 
chemical composition of the species. 
Research methodology 
To recognize pertinent information on the botany, medicinal 
uses, phytochemistry and biological activities of C. wightii, a 
review was compiled based on scientific literature from 
various sources including Google Scholar, Web of Science, 
SciFinder, Scopus, Science Direct, PubMed, Scielo, 
Springerlink, Google Patents, Espacenet, BioMed Central 
(BMC) and Medline. The keywords used for recognition of 
relevant data included dissimilar scientific name and 
synonyms, common English names, and the terms: biological 
activities, medicinal uses, ethnobotany, ethnopharmacology, 
medicinal, pharmacology, phytochemistry and therapeutic 
value, C. wightii, Commiphora mukul Hook. ex. Stocks. 
Further literatures were obtained from books, book 
chapters, theses, websites and conference proceedings. 
Occurrence and distribution 
The C. wightii plant present in arid and semi arid climate and 
it’s tolerant of poor soil. The C. wightii plant mainly 
distributed in arid area of northern Africa to central Asia, but 
it most common in Rocky track of western India and Eastern 
Himalayas. In central Asia the C. wightii plant is distributed 
in arid areas of India, Bangladesh and Pakistan. In India it 
plant found in arid, Rocky tracts of Rajasthan, Gujarat, 
Maharashtra, Madhya Pradesh and Karnataka. According to 
Ayurveda, there are five type of Guggul namely; Krishnan 
(black), Peet Varn (Yellow), Neel (blue), Kapish (light 
brown) and Rakt (blood red). It is propagated by seeds and 
root cuttings11-13. 
Morphology 
C. wightii is a woody shrub or a small tree which grows to 
the height of 2-3 metres, much branched with characteristics 
silvery and paper like bark-peelings. Branches are knotty 
and crooked, divaricate, usually ending in a sharp spine. 
Leaves: The leaves are rhomboid-ovate, 1-3 foliate, serrate-
toothed in the upper part, smooth and shinning, the lateral 
leaflets when present less than half the size of the terminal 
ones. Flowers: Flowers in the fascicles of 2-3; pedicles very 
short. Calyx campanulate, glandular, hairy; lobes are 4-5 in 
number, triangular, as long as the tube. Petals are brownish 
red, broadly linear, nearly thrice the length of the calyx, 
reflexed at the apex. Stamens are 8-10 in number, 
alternatively long and short, half the length of the petals. 
Disk, 8-10 lobed, the alternate sinuses deeper and in these 
are inserted the shorter stamens. Ovary oblong-ovoid, 
attenuated into the style. Fruits: The fruits are small, red in 
colour when ripe, ovoid drupes. Each plant produces about 
0.5 to 1kg of oleo-gum resin which is collected from January 
to March. Gum Resin: Pale yellow to brown aromatic gum 
resin obtained from the bark of the plant. Agglomerated 
tears of resin are somewhat transparent, with waxy surface 
and brittle in nature. Gum-resin is thick, scented, burnt on 
fire, liquifies in sun heat. When dissolved in water, it turns 
milky white14-16.  
Macroscopic and microscopic features  
Macroscopic C. wightii occurs in vermicular pieces of pale 
yellow or brown colored mass with aromatic odour and 
bitter astringent taste; when fresh it is viscid and golden 
colored. Makes milky emulsion in hot water and readily 
burns. Tears of varying sizes, reddish yellow or brown in 
color, more often occurring in resinous lumps which turn 
darker in color on long storage. Fracture-brittle, exposing a 
rough or waxy surface having a moist unctuous appearance; 
balsamic odour, acrid, bitter and aromatic taste. 
Microscopic Foreign matter Not more than 4 %; Total Ash 
Not more than 5 %; Acid-insoluble ash Not more than 1%; 
Alcohol-soluble extractive Not less than 27 %; Water-soluble 
extractive Not less than 53%; Volatile oil Not less than 1%, 
v/w and between 1.0 and 1.5 percent of guggulsterones (𝑍 
and 𝐸)17,18. 
Phytochemical constituents 
C. wightii contains diterpenoids, triterpenoids, steroids, 
longchain aliphatic tetrols, aliphatic esters, ferulates, lignans, 
carbohydrates, and a variety of inorganic ions besides minor 
amounts of sesamin and other unidentified constituents. 
1. Volatile oil and its terpenoidal constituents  
Monoterpenoids The gum resin of C. wightii yields about 
0.4% of essential oil by steam distillation and its chief 
components are myrcene, dimyrcene, and polymyrcene19. 
Other components of the oil are eugenol, d-limonene, 𝛼- 
pinene, (±) linalool, cineole, 𝛼-terpineol, d-𝛼-phellandrene, 
methylheptanone, bornyl acetate, (±) geraniol, and some 
other unidentified compounds20. 
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Sesquiterpenoids The gum resin of C. wightii has been 
reported to contain bicyclic sesquiterpene, cadinene20.  
Diterpenoids Diterpenoid constituents from guggulu include 
𝛼-camphorene, cembrene-A, cembrene21 and other 
cembrenoids. Cembrene-A is one of the most elementary 
tetraenes derived from geranylgeranyl pyrophosphate by C-
1 to C-14 cyclization. Mukulol (allylcembrol) is a new 
cembrane alcohol which was isolated from the aerial parts 
and also from the resin of guggulu22,23. The allylcembrol 
structure was established by spectral analysis and mild 
dehydration which yielded cembrene. Other isolated 
cembrane type diterpenes include isocembrol and 4-
epiisocembro. (1𝐸, 4𝐸, 8𝐸)-4,8,14-Trimethyl11-(1-
methylethyl)4-methoxycyclotertradeca-1,4,8-triene, (2𝐸, 
12𝐸)-2,7,13-trimethyl-9-(1-methylethyl)-15- oxabicyclo 
[12.1.0] pentadeca-2,12-diene-7-ol and (4𝑍, 6𝐸)-
4,7,12,15,15-pentamethylbicylco [9.3.1] pentadeca-4,6-
diene-12-olwere novel compounds obtained by bioassay-
guided isolation from hexane-soluble portion of the 
methanol extract of guggulu24.  
Triterpenoids Polypodane-type triperpenes, myrrhanol A, B, 
and C, myrrhanone A, myrrhanone B, myrrhanone A acetate, 
commipherol, commipherin, and octanordammarane 
triperpenoid, epimansumbinol have been isolated from the 
gum resin. The isolation of two more triterpenoidal 
components has been reported, which are identified as 
mansumbinone and mansumbinoic acid25-28. The absolute 
stereo structure of myrrhanol A was determined to be (3𝑆, 
5𝑆, 8𝑅, 9𝑅, 10𝑆)-3, 8,30-trihydroxypolypoda-13𝐸, 17𝐸, 21𝐸-
triene. Myrrhanol B is 30-oic acid of myrrhanol A with 
altered stereostructure at C-5 (5𝑅 in contrast to 5𝑆 in 
myrrhanol A). Myrrhanone A and B are 3-keto analogue of 
myrrhanol A and B, respectively26. A myrrhanone derivative, 
(13𝐸, 17𝐸, 21𝐸)-8-hydroxypolypoda-13, 17, 21-trien-3-one 
and a myrrhanol derivative, (13𝐸, 17𝐸, 21𝐸)-polypoda-13, 
17, 21-trien-3, 18-diol have also been isolated24. 
2. Steroids Isolation of several steroidal constituents has 
been reported from the gum resin. The major constituents 
include E-guggulsterone, Z-guggulsterone, guggulsterol-1, 
guggulsterolII, guggulsterol-III, guggulsterol-IV, 
guggulsterol-V and guggulsterol-VI. Other isolated steroids 
are 20𝛼-hydroxy-4-pregnen-3-one, 20𝛽-hydroxy-4-pregnen-
3-one, and 16𝛽- hydroxy-4, 17 (20)-Z-pregnadien-3-ones 
which has been designated as Z-guggulsterol29-32. 
Progesterone and related steroids, 4-pregnene-3, 16-dione, 
(20R)- 20-acetoxy-4-pregnene-3,16-dione,16𝛽-
acetyloxypregn4,17(20)-trans-diene-3-one, 3𝛼-acetyloxy5𝛼-
pregnan-16-one and 20R,22R-dihydroxycholest-4-en-3-one 
have also been isolated27. Cholesterol has also been 
reported. Three new and recently isolated steroids are 
guggulsterone-M, dihydro guggulsterone-M and 
guggulsterol-Y28. The steroidal constituents have been 
related with hypolipidemic and anti-inflammatory activities 
of the drug24.  
3. Flavonoids An ethanolic extract of trunk of C. wightii was 
separated on column packed with silica gel to give a new 
antifungal flavone named muscanone along with known 
naringenin. Muscanone was found to be active against C. 
albicans in microbial sensitive assay. The major flavonoid 
components of the flowers of C. wightii were identified as 
quercetin, quercetin-3-O-𝛼-L-arabinose), quercetin3-O-𝛽-D-
glucuronide, quercetin-3-O-𝛽-Dgalactoside, quercetin-3-O-𝛼-
L-rhamnoside and pelargonidin-3, 5, di-O-glucoside32,33.  
4. Guggultetrols A crystalline material was isolated from 
the saponified gum resin which was characterized as a 
mixture of octadecan-1,2,3,4-tetrol, nonadecan1,2,3,4-tetrol 
and eicosan-1,2,3,4-tetrol with minor amount of other 
components, possibly lower (C-16 and C-17) and higher (C-
21 and C-22) homologous tetrols. These compounds 
constitute a new class of naturally occurring lipids, 
guggultetrols. They are long-chain linear aliphatic tetrols 
with hydroxyl functions at C-1, C-2, C3, and C-4 positions. 
Through derivatization and preparative GLC, guggultetrol-18 
and guggultetrol-20 were obtained in pure form. A mixture 
of two ferulates (𝑛 = 16, 17) with an unusual skeleton was 
found to be responsible for the cytotoxic action of the drug. 
They have been isolated from cytotoxic fraction of ethyl 
acetate extract of guggulu. It was identified as a mixture of 
esters based on homologous longchain tetrols and acid34,35. 
5. Lignans Two lignans, sesamin29 and diayangambin36 have 
been reported from guggulu. Also, 5,5-tetrahydro-1𝐻,3𝐻-
furo[3,4-c]furan-1,4-diylbis[7- (methoxy)-1,3-benzodioxole] 
has been reported from methanolic extract of guggulu24. 
6. Sugars Complete hydrolysis of gum part of resin yielded 
L-arabinose, D-galactose, L-fructose (traces) and 4-O-
methyl-D-glucuronic acid. Graded hydrolysis of the gum 
furnished an aldobiouronic acid [6-O-(4-O-methyl-𝛽- D-
glucopyranosyluronic acid)-D-galactose]. Hydrolysis of 
methylated gum furnished 2,3,4,6-tetra-O-methyl-
Dgalactose, 2,3-di-O-methyl-L-arabinose, 2,3,4-tri-O-
methylD-galactose, 2,4-di-O-methyl-D-galactose, and 2,3,4-
tri-Omethyl-D-glucuronic acid in the ratio of 1 : 1 : 1 : 2 : 1. 
The provisional structure showed the gum to be a highly 
branched polysaccharide containing 1-6, 1-3,- and 1-5 type 
of linkage37,38. 
7. Amino Acids C. wightii was extracted with alcohol and the 
extract after removal of the solvent was partitioned between 
water and ether. The aqueous fraction was 
chromatographed and it showed the presence of various 
amino acids. The amino acids detected were cystine, 
histidine, lysine, arginine, aspartic acid, serine, glutamic acid, 
threonine, alanine, proline, tyrosine, tryptophan, valine, 
leucine, and isoleucine39. 
Cultivation  
C. wightii is sought for its gummy resin, which is harvested 
from the plant’s bark through the process of tapping. In 
India, C. wightii is cultivated commercially. It can 
successively be propagated by vegetative means. The rooting 
initiates 21 days after sprouting and 300mm, long 15 and 
15mm diameter cutting gives the maximum rooting. As it is a 
plant of arid zone, there is no necessity of irrigation upto the 
middle of November except during drought. However, if 
there is the winter shower, there is a necessity of irrigation 
to plants of one to five years of age group. The plants of 6-7 
years of age group require irrigation only in summer season. 
Irrigation can be done either by head load method or water 
tank method40,41. 
Medicinal uses 
The use of C. wightii plant in the treatment of diseases 
occupies an important place in ayurveda, the traditional 
medicine system of india. The Atharvaveda one of the four 
well known holy scriptures (Vedas) of the Hindus, the 
Atharvaveda is the earliest reference for it medicinel and 
therapeutic properties42. Detained description regarding it 
action, use and induction as well as the varieties of guggul 
have been described in numerous Ayurvedic treat including 
Charaka samhita (1000 BC), Sushruta Samhita (600 BC and 
Vagbhata seventh century AD). In addition, various medical 
lexicons were return between twelth and forteen centuries 
AD. It responsible for reducing fat, indicated for healing 
Bone Fracture to inflammation, Arthritis, Atherosclerosis, 
Obesity, Hyperlipidemia, Rheumatism, Haemorrhids, 
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Urinary disorder, skin disease high cholesterol, neuro-
degenertion, Parkinson's diseases, mongolism and ageing 
process43-48. C. wightii is a gum resin, historically used for 
antiseptic and deep penetrating action in the treatment of 
elevated blood cholesterol and Arthritis. C. wightii is 
effective as weight loss and fat burning agent. It increase 
white blood cell count and possess strong disinfecting 
properties. Used as a carrier and combined with other herbs 
to treat specific condition44,49,50. Traditionally, C. wightii 
plant is given in the form of YOG, where in C. wightii is mixed 
with other drug’s along with castor oil or Indian clarified 
butter. The YOG could also be prepared by cooking the C. 
wightii with water, and other herbal drug powder. Popular 
Ayurvedic formulated containing C. wightii are: Yograj 
gugguluvati, Pachamrit ioh guggulu, Kaishore gugguluvayi, 
Triphla guggulu and Sinhaguggluvati51. C. wightii has been a 
key component in ancient Indian Ayurvedic system of 
medicine and now widely use in Morden medicine for 
treatment of heart ailments. But C. wightii as it’s locally 
known, has become so scarce because of its overuse in it two 
habitats in india where it found-Gujarat and Rajasthan. The 
extract, called guggulipid, comes from the C. wightii tree and 
has been used in Ayurvedic medicine, a traditional Hindu 
medicine, for nearly 3000 years in India. Today it existence 
is threatened because of iow seed production in an adverse 
natural condition and recent environmental change due to 
rainfall pattern and increasing level of atmospheric 
pollution. This plant species is fighting for its survival in the 
natural habitat since a long time. Attempts have been made 
in this direction by number of researchers including under 
present investigation towards its natural populations, germ-
plasm collection, cultivation techniques, Phytosociology and 
regeneration potentialities etc. at different site of Western 
Indian Thar desert44,52. The oleo-gum resin commonly 
known as “gum guggul” or “Indian Myrrh” is the 
economically important product of Indian bdellium. The 
oleo-gum is collected as exudates from woody stem. A plant 
generally takes 10 years to reach tapping maturity under the 
dry climate conditions. The thick branch is incised during 
the winter to extract the oleo-gum resin. Guggul gum is a 
mixture of 61% resin, and 29.3% gum, in addition to 6.1% 
water, 0.6% volatile oil and 3.2% foreign matter53. 
Reported pharmacological activities 
 Hypolipidemic/ Hypocholesterolaemic activity  
1. Crude Guggulu was reported to possess highly 
encouraging hypolipaemic activity in rabbits54.  
2. Anion exchange property detected by means of 
chloride retention and bile acid sequestrating activity 
in the oleoresin fraction hypocholesterolaemic 
activity55.  
3. Crude drug as well as its two fractions (alcohol soluble 
and alcohol insoluble) were found to cause a significant 
fall in serum cholesterol and serum turbidity with a 
concomitant increase in the coagulation time and 
prothrombin time. The alcohol insoluble fraction was 
slightly more potent in this respect than alcohol 
soluble fraction as well as crude Guggulu56.  
4. PE fraction A (petrol-soluble), B (alkali washed neutral 
portion) and C (petrol-insoluble) were given to 8 week 
old male white leg horn chicks for 2-3 weeks in 
hypercholesterolaemia induced by atherogenic diet. All 
fractions lower the serum cholesterol, but fraction A is 
most potent and B is the least potent57. 
5. Alcohol extract and two pure fractions (a terpenoid 
and a steroid) isolated from the PE extract showed that 
the steroid fraction was highly potent as hypolipaemic 
agent lowering the serum cholesterol by 69.3% as well 
as the c/p ratio. The alcohol extract could lower the 
cholesterol by 59.2% whereas the Terpenoid lowered 
it by 54.3%58. 
6. The alcohol extract of Guggulu when orally 
administrated to Indian domestic pigs kept on 
standard atherogenic diet over a period of six weeks 
effectively reduced the total serum cholesterol and also 
serum beta-lipoprotein fraction and significantly 
altered the lipoprotein ratio59.  
7. The steroidal compound isolated from fraction A of PE 
extract reduced the lipid content (Viz., total lipids, 
cholesterol, TG and phospholipids) of both hepatic and 
aortic tissues. The response was doses-dependent and 
the maximum effect was noted at 10mg/kg60.  
8. Fraction A of PE extract of C. mukul, effectively lowered 
serum lipids, cholesterol, phospholipids and 
triglycerides in monkeys fed with cholesterol diet61.  
9. Alcoholic extract (25-50 mg/kg orally), reduced serum 
cholesterol level in normal and hyperlipaemic rats and 
rabbits. Further, a resin fraction, a pure steroid and 
fraction F isolated from crude extract showed 
hypocholesterolaemic effect on normal and triton-
induced hyperlipaemic rats62,63.  
10. The hypolipidemic activity was shown in animals as 
well as in patients of obesity and 
hypercholesterolemia64.  
11. A number of clinical studies were carried out to 
confirm hypolipidemic activity of guggulu and 
gugulipid65,66. 
12. In another study, highly significant reduction in levels 
of mean serum cholesterol and triglyceride was 
observed in groups of animals receiving high-fat diet 
for one month along with guggulu, which clearly 
demonstrated its hypolipidemic activity. Additionally, 
administration of guggulu partially reversed the 
atherosclerosis in the aorta that was induced by high-
fat diet67 . 
13. Clinical studies on C. mukul showed its hypolipidemic 
effect and the outcome of change in lipid profile upon 
its administration. This study showed significant 
decrease in total cholesterol and LDL cholesterol after 
treatment with guggulu68. 
14. The hypolipidemic activity of the isomers 𝐸-
guggulsterone and𝑍-guggulsterone has also been 
studied in animalmodels. Administration of 
guggulsterone (𝑍 and 𝐸) significantly lowered 
serumlipid levels of rats with either triton (WR-1339) 
or cholesterol-induced hyperlipidemia69. 
 Effect on Platelet Aggregation and Fibrinolytic 
Activity 
1. The purified steroid mixture from guggulu completely 
inhibited ADP, adrenaline, or serotonin induced 
platelet aggregation. No difference was observed 
between the effectiveness of the steroid mixture and 
the purified guggulsterone 𝐸 or 𝑍. The effect of 
guggulsterones 𝐸 and 𝑍 was very similar to the 
inhibitory effect of clofibrate. This finding has 
therapeutic value in myocardial infarction and 
thromboembolism70. 
2. The effect of guggulu on fibrinolysis and platelet 
adhesiveness in coronary heart disease was studied. 
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Guggulu fraction A (pet ether extract) in daily dose of 1 
g was administered to healthy individuals (group I) 
and to patients of coronary artery disease (CAD) 
(group II) for a period of 30 days. Serum fibrinolytic 
activity increased, while the platelet adhesive index 
decreased, which was statistically significant in healthy 
individuals and in CAD patients. In view of this, 
guggulu fraction A may be a useful therapeutic agent in 
the management of coronary artery disease71. 
 Thyroid Stimulatory Activity 
1. Administration of ethanolic extract of guggulu to the 
female albino mice for 15 days enhanced the 
triiodothyonine (T3) concentration and T3/T4 
ratio,while nomarked change in the concentrations of 
serum thyroxine (T4) was observed72. 
2. 𝑍-Guggulsterone was shown to be responsible for the 
thyroid stimulatory action of guggulu. Administration 
of isolated 𝑍-guggulsterone to rats led to significant 
increase in all thyroid function parameters, namely, 
uptake of iodine by the thyroid, enzymes involved in 
the synthesis of thyroid hormones, and tissue oxygen 
uptake, thus suggesting thyroid stimulatory action73. 
 Anti-inflammatory and Anti-arthritic activity 
1. Oleoresin was found to be highly potent anti-
inflammatory agent, as compared to hydrocortisone 
and butazoladin against Brownlee’s for maldehyde-
induced arthritis in albino rats74.  
2. Oleoresin fraction possesed significant anti-arthritic 
and anti-inflammatory activities, the minimum 
effective dose being 12.5mg/100g body weight. Only 
the acidic fraction showed significant activity while the 
monoacid and solid fractions were inactive75 .  
3. The Steroidal compound isolated from PE extract 
possessed significant anti-inflammatory activity on 
carrageenin-induced rat-paw oedema76,77. 
4. The results of several studies confirm anti-
inflammatory and antiarthritic activities of guggulu78-
82.  
5. The 50 percent aqueous methanolic extract was found 
to exhibit an anti-inflammatory effect on adjuvant-
induced air pouch granuloma in mice. The methanolic 
extract inhibited nitric oxide production in 
lipopolysaccharide activated mouse peritoneal 
macrophages83. 
6. Guggulosomes prepared using guggul with ibuprofen 
by bath sonication and trituration methods were 
studied for anti-inflammatory activity. It was clearly 
shown that guggulosomes had more efficacy than 
ibuprofen and both guggul and ibuprofen had 
synergistic effect. The study proved that guggul could 
serve as a carrier for entrapping drugs and for their 
sustained release action84.  
7. Several animal studies have demonstrated the 
effectiveness of guggulu extract in standard 
osteoarthritis (OA) models. The authors had conducted 
both animal and clinical investigations of guggulu for 
OA prior to this study. The goal of this study was to 
determine the effectiveness of guggulu for reduction of 
pain, stiffness, and other symptoms that arise from 
OA85. 
 
 
 Antiatherosclerotic Activity 
1. LDL has been found to accumulate in atherosclerotic 
lesions and is the major source of the cholesterol 
accumulation in human foamcells.There is evidence 
that LDL oxidation is essential for atherogenesis and 
the antioxidants that prevent this oxidation may either 
slow down or prevent atherogenesis. Guggulsterones, 
the lipidlowering components of guggulu, effectively 
inhibited in vitro LDL oxidation (as discussed under 
antioxidant action). Thus the combination of 
antioxidant and lipid-lowering properties of guggulu 
makes it especially beneficial against atherogenesis86. 
 Cardioprotective Activity 
1. Guggulsterones are shown to be effective 
cardioprotectives. Myocardial necrosis induced by 
isoproterenol in rats caused marked increase in serum 
creatine phosphokinase and glutamate pyruvate 
transaminase. Phospholipase, xanthine oxidase, and 
lipid peroxides were simultaneously enhanced in 
ischemic heart following depletion of glycogen, 
phospholipids, and cholesterol. Treatment with 
guggulsterone at a dose of 50mg/kg significantly 
protected cardiac damage as assessed by the reversal 
of blood and heart biochemical parameters in ischemic 
rats87 . 
 Antifertility Activity 
1. Guggulu administered orally (2 and 20mg/100 g body 
weight) to female rats decreased the weight of the 
uterus, ovaries, and cervix, whereas glycogen and sialic 
acid levels in these organs increased. This suggested 
that guggulu may be useful as an antifertility agent88. 
 Skin Diseases 
1. Administration of gugulipid was reported to be 
effective in the treatment of nodulocystic acne. A study 
in 21 patients found that gugulipid was as effective as 
tetracycline in the treatment. The patients with oily 
faces responded better to the gugulipid treatment89. 
 Antihyperglycemic Activity 
1. Administration of alcoholic extract of C. mukul at a 
dose of 200mg/kg for 60 continuous days reduced 
plasma glucose levels in streptozotocin-induced 
diabetic rats90. 
2. A study showing effect of guggulsterone isolated from 
C. mukul in high-fat diet induced diabetic rats has also 
been reported.Different biochemical parameters like 
GTT, glycogen content, glucose homeostatic enzymes 
(like glucose-6-phosphatase and hexokinase), insulin 
release in vivo, and expression profiles of various genes 
involved in carbohydrate and lipid metabolism clearly 
demonstrated the hypoglycemic effect.Theresults 
suggested that guggulsterone has both hypoglycemic 
and hypolipidemic effects which can help cure type II 
diabetes91. 
 Antimicrobial Activity 
1. The volatile oil of C mukul was found to be highly 
effective against Rhyzopertha dominica which 
suggested its role as a fumigant. The ethanolic extract 
of C. mukul exhibited best antibacterial activity at 5mg/ 
ml against multidrug-resistant Klebsiella pneumonia92.  
2. An active compound, 5(1-methyl,1-aminoethyl)-5-
methyl-2- octanone, of the methanolic extract of 
guggulu gum possessed significant antibacterial 
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activity against Gram-positive bacteria and moderate 
activity against Gram-negative bacteria93-95. 
 Cytotoxic Activity 
1. Ferulate compounds are used in the method for 
prevention and treatment of abnormal cell growth and 
proliferation of inflammation, neoplasia, and 
cardiovascular disease. Ethyl acetate extract showed 
significant in vitro cytotoxicity. A fraction showing 
cytotoxic activity was characterized as a mixture of two 
ferulates with an unusual skeleton by spectral and 
chemicalmethods.This fraction also showed moderate 
scavenging effect against 2,2-diphenyl-1- picryl 
hydrazyl (DPPH) radicals96.Treatment with gugulipid 
significantly inhibited the viability of human prostate 
cancer cell line LNCaP (androgendependent)and its 
androgen-independent variant (C-81) with IC50 of 1 
𝜇M(24 h treatment), thus indicating its possible role in 
apoptosis and cancer prevention96. The results of this 
study indicated that guggulsterone inhibited 
proliferation of PC-3 cells in culture by causing 
apoptosis, whereas a normal prostate epithelial cell 
line is resistant to growth inhibition and apoptosis 
induction by this phytoconstituent. These observations 
provided rationale for further preclinical andclinical 
evaluationof guggulsterone for its efficacy against 
prostate cancer97. 
Substitutes and Adulterants  
Oleo-gum resin obtained from Boswellia serrata Roxb. (Salai 
guggulu) is the major adulterant. It is distinguished by its 
yellowish green, golden or milky tears, seldom amalgamated 
into lumps and a characteristic terpentine like odour. Gum-
oleo-resin of Commiphora myrrha (Nees) Engl. imported 
from Africa and constituting the drug Hirabole or bole of 
commerce is sometimes mixed with Guggulu. Similarly, gum-
oleo-resin obtained from Commiphora roxburghii (Arn) 
Engl., Occurring in central and eastern India is sold by the 
name of Guggulu. The former is distinguished by large tears 
of yellowish brown colour, exposing, on fracture, a brown 
surface having white markings, while the latter has a bluish 
tinge and a feeble balasmic odour98. 
Possible Reasons for Its Decline  
Several reasons are cited for the plant being listed as en-
dangered species and some of these are considered to be of 
greater consequences affecting its population survival. The 
various factors are: slow growth, poor seed-setting and seed 
germination rate, lack of cultivation, unsustain-able over-
exploitation, excessive and unscientific tapping method, 
invasion of alien species99-101. These have been listed below. 
1. Unscientific method of tapping and overexploitation 
2. Low seed setting 
3. Regeneration through seeds 
4. Invasion of alien species 
5. Others 
 Narrow extent of occurrence, small area of occupancy 
and severe fragmentation, as other reasons for 
conservation threat and extinction risk. 
 It has never been brought under cultivation. 
 The changing environment and existing natural 
populations of this species has been af-fected by 
climatic conditions, soil erosion, low rainfall, termite 
infestation, over-grazing by domestic animals and 
mining activities. 
Safety and Toxicity 
It has beenmentioned in Ayurvedic texts that administration 
of raw guggulu may sometimes lead to skin rashes, irregular 
menstruation, diarrhoea, headache, mild nausea, and, with 
very high doses, liver toxicity102. In order to overcome the 
side effects of raw guggulu, Ayurveda describes a number of 
purification processes (shodhan vidhi) in different 
“dravyas,” that is, fluids, which not only take care of the 
adverse effects but also enhance the therapeutic activity17. It 
is also mentioned in Ayurvedic texts that guggulu must be 
purified before incorporation into herbal formulations. 
There are a large number of commercial polyherbal anti-
inflammatory formulations which are using guggulu as the 
chief ingredient82. The clinical trials done with standardized 
gum guggul extracts reported transient side effects such as 
skin rashes, diarrhoea, and irregular menstruations. A report 
also states that, out of 22 individuals receiving 2160mg 
guggulu daily for 12 weeks, 10 persons experienced one or 
another side effect including gastrointestinal distress, 
fatigue, and skin rash103. Skin rashes have also been reported 
in other trials using 1-2 g guggulipid (ethyl acetate fraction) 
daily for a month. This study did not report any intestinal 
distress104 . Although generally accepted as relatively safe, 
caution may be warranted during guggul consumption. 
There is little or no information on toxicity with the use of 
guggulu. 
Conclusion 
In the present review, we have made an effort to provide the 
mophological, phytochemical, ethnopharmacological and 
pharmacological information on C. wightii, a tree used 
conventionally for medicinal purposes. A variety of extracts 
and chemical compounds of the plant have shown 
Hypolipidemic/ hypocholesterolaemic activity, Effect on 
platelet aggregation and fibrinolytic activity, thyroid 
stimulatory activity, antioxidant, antibacterial, cytotoxic, 
anti-inflammatory and hypoglycaemic activities. Its 
phytochemical composition indicates the presence of 
diterpenoids, triterpenoids, steroids, longchain aliphatic 
tetrols, aliphatic esters, ferulates, lignans, carbohydrates, 
and a variety of inorganic ions besides minor amounts of 
sesamin and other unidentified constituents. A large number 
of compounds have been isolated from C. wightii and shown 
to possess assorted biological properties. In addition, crude 
extracts of the plant and their solvent fractions are 
connected with diverse pharmacological activities. 
Ethnopharmacological research on C. wightii is heartening as 
phytochemical profiling, nutritional and biological activities 
of the species could support the documented medicinal uses, 
nutritional and nutraceutical properties of C. wightii. 
Comprehensive research on phytochemical properties, 
biological activities, pharmacokinetics and clinical trials of C. 
wightii is required as this will present further confirmation 
for the nutritional, ethnopharmacology and nutraceutical 
potential of C. wightii. Further research should center on 
experimental in vitro, in vivo studies and toxicological 
evaluation of C. wightii and its phytochemical compounds. 
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